Zomedica Corp.
ZOMDF
$0.05
$0.014540.85%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.33% | 16.23% | 25.68% | 33.05% | 42.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.33% | 16.23% | 25.68% | 33.05% | 42.44% |
| Cost of Revenue | 7.48% | 19.52% | 37.19% | 44.05% | 66.45% |
| Gross Profit | 13.10% | 14.80% | 20.85% | 28.59% | 33.59% |
| SG&A Expenses | 26.50% | 25.16% | 24.38% | 31.42% | 18.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.70% | 29.80% | 32.00% | 38.98% | 25.22% |
| Operating Income | -50.99% | -41.51% | -37.20% | -44.11% | -12.36% |
| Income Before Tax | -249.26% | -174.87% | -82.79% | -85.04% | 15.96% |
| Income Tax Expenses | 104.33% | -12.38% | 9.36% | 43.79% | 22.25% |
| Earnings from Continuing Operations | -316.46% | -188.03% | -91.69% | -102.96% | 14.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -316.46% | -188.03% | -91.69% | -102.96% | 14.64% |
| EBIT | -50.99% | -41.51% | -37.20% | -44.11% | -12.36% |
| EBITDA | -54.75% | -41.55% | -34.41% | -41.46% | -4.04% |
| EPS Basic | -314.38% | -186.93% | -91.46% | -102.87% | 14.53% |
| Normalized Basic EPS | -72.44% | -53.73% | -38.97% | -35.48% | 7.97% |
| EPS Diluted | -314.38% | -186.93% | -91.46% | -102.87% | 14.53% |
| Normalized Diluted EPS | -72.44% | -53.73% | -38.97% | -35.48% | 7.97% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
